Are the green shoots starting to emerge for the junior market? Well, it certainly seems to be the case with…
By IAN LYALL AT PROACTIVE INVESTORS FOR THISISMONEY.CO.UK Updated: 13:27, 10 March 2025 A 42 per cent profit. That’s what…
Electric vehicles are constantly improving, but there’s no doubt these ever-evolving petrol and diesel alternatives still face scrutiny from consumers.Whether…
For ambitious junior life sciences companies, often the ultimate goal is securing partnerships with well-funded industry players to propel drug…
Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.Shares…
Britain is no longer the industrial powerhouse it once was, having ceded its dominance in manufacturing to the US, Germany,…
Switzerland will cap its population to ten million as part of an immigration crackdown under plans put forward by the…
Why must everything be subscription-based these days?From entertainment, fitness, food and wine to beauty products and even underwear, it feels…
Allergy Therapeutics is writing a story of resilience and transformation. Putting behind it manufacturing setbacks, the company has redefined its…
Quiz fell victim to the retail sector’s wider woes in November as a “marked drop” in footfall weighed on sales…